arrow
M

Merve Hasanov

the ohio state university comprehensive cancer center
H指数:7
被引数:269

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TLSB-25 SINGLE-CELL CHARACTERIZATION OF RENAL CELL CARCINOMA BRAIN METASTASIS

TLSB-25 肾细胞癌脑转移的单细胞表征

2026-08-070
OA
Second-line treatments for patients with programmed cell death protein 1-refractory cutaneous squamous cell carcinomas: a brief report

AlSharif, H.; Danchine, V.; Deekollu, K.; Hasanov, M.; Wu, R.; Haykal, T.; Faieta, A.; Verschraegen, C.F. 程序性死亡蛋白1耐药的皮肤鳞状细胞癌患者的二线治疗:一份简要报告。Oncologist 2026, 31, oyag038. [Google Scholar] [CrossRef]

2026-04-011
PRE
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy

Savardekar H, 等人. BRD4抑制可导致MDSC凋亡并增强检查点阻断疗法。临床研究杂志. (2025). doi: 10.1172/JCI181975

2025-10-012
OA
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

淋巴细胞清除、肿瘤浸润淋巴细胞,以及高剂量与低剂量IL-2后给予pembrolizumab在转移性黑色素瘤患者中的应用

2025-08-150
OA
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

黑色素瘤脑转移患者总体生存相关的分子和临床特征的综合分析

2025-04-150
OA
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort study
2024-04-101
OAAI
Phase II study of pembrolizumab in conjunction with lymphodepletion, TIL ACT, and high- or low-dose IL-2 in patients with metastatic melanoma
2024-03-220
PRE
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

黑色素瘤脑转移患者预后和生存相关因素的变化

2022-12-1310
OAAI
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

肾细胞癌患者脑转移治疗的跨学科共识

2022-06-1617
OAAI